Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease BEFREE Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]). 30719842 2019
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 Biomarker disease GENOMICS_ENGLAND MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). 25612909 2015
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease UNIPROT Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. 24183479 2014
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease UNIPROT A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia. 23326516 2013
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease UNIPROT Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction. 20371544 2010
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 Biomarker disease GENOMICS_ENGLAND Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. 19949040 2009
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease UNIPROT Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. 19949040 2009
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 Biomarker disease MGD A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions. 18718936 2008
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease UNIPROT MUSK, a new target for mutations causing congenital myasthenic syndrome. 15496425 2004
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 GeneticVariation disease CLINVAR
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY
0.810 CausalMutation disease CLINVAR
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GeneticVariation disease BEFREE Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]). 30719842 2019
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 Biomarker disease BEFREE Here we identify MUSK as a novel cause of lethal FADS. 25537362 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GermlineCausalMutation disease ORPHANET Here we identify MUSK as a novel cause of lethal FADS. 25537362 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 Biomarker disease GENOMICS_ENGLAND MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). 25612909 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 Biomarker disease GENOMICS_ENGLAND Here we identify MUSK as a novel cause of lethal FADS. 25537362 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GeneticVariation disease UNIPROT Here we identify MUSK as a novel cause of lethal FADS. 25537362 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GermlineCausalMutation disease ORPHANET MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). 25612909 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GeneticVariation disease UNIPROT MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). 25612909 2015
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GeneticVariation disease BEFREE Pena and Shokeir described the phenotype of two sisters in 1974, and subsequently their features have become recognized as a sequence of deformational changes related to decreased or absent fetal movement (fetal akinesia deformation sequence [FADS]), because of the work of Moessinger (1983). 19645055 2009
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 CausalMutation disease CLINVAR
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 Biomarker disease HPO
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 Biomarker disease CTD_human
CUI: C1276035
Disease: Pena-Shokeir syndrome type I
Pena-Shokeir syndrome type I
0.730 GeneticVariation disease CLINVAR
CUI: C0751882
Disease: Myasthenic Syndromes, Congenital
Myasthenic Syndromes, Congenital
0.370 GeneticVariation disease BEFREE Defects in muscle, skeletal, receptor tyrosine kinase (MuSK) cause two distinct phenotypes: fetal akinesia with multiple congenital anomalies (Fetal akinesia deformation sequence [MIM:208150]) and early onset congenital myasthenia (myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency [MIM:616325]). 30719842 2019